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Abstract
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Genetic ablation of the ferrireductase STEAP3, also known as TSAP6, leads to severe microcytic
and hypochromic red cells with moderate anemia in the mouse. However, the mechanism leading
to anemia is poorly understood. Previous results indicate that TSAP6/Steap3 is a regulator of
exosome secretion. Using TSAP6/Steap3 knockout mice, we first undertook a comprehensive
hematologic characterization of the red cell compartment, and confirmed a dramatic decrease in
the volume and hemoglobin content of these erythrocytes. We observed marked anisocytosis as
well as the presence of fragmenting erythrocytes. Consistent with these observations, we found by
ektacytometry decreased membrane mechanical stability of knockout red cells. However, we were
unable to document significant changes in the expression levels of the major skeletal and
transmembrane proteins to account for this decrease in the membrane stability. Furthermore, there
were no differences in red cell survival between wild type and knockout animals. However, when
we monitored erythropoiesis, we found a decreased number of proerythroblasts in the bone
marrow of TSAP6/Steap3−/− animals. In addition, progression from the proerythroblastic to the
orthochromatic stage was affected, with accumulation of cells at the polychromatic stage.
Altogether, our findings demonstrate that abnormal erythroid maturation is the main cause of
anemia in these mice.
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Introduction
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During erythropoiesis, the differentiating red cell acquires properties that make it unique in
terms of deformability and stability. At the membrane, two multi-protein complexes and
underlying cytoskeleton are assembled, which allow the red cell to deform as it passes
through the blood capillaries to deliver oxygen throughout the body [1]. In adult mammals,
hemoglobin, which accounts for 90% of the total protein content of the red cell, consists of a
heterotetramer composed of two alpha- and two beta-globin chains (α2β2) non-covalently
bound to a heme group. A charged atom of iron is at the center of the heme group, and is
essential for the oxygen-carrying function of hemoglobin [2]. The iron used in hemoglobin
synthesis comes from recycled iron.
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In the circulation, oxidized iron (Fe(III)) is bound to transferrin (Tf). Once differic (Fe(III)2)
loaded-transferrin binds to its receptor (Transferrin Receptor-1, TfR1), subsequent
endocytosis allows iron to be delivered to the endosomal compartment in the erythroblast
[3]. During mammalian erythropoiesis, expression of TfR1 is finely regulated, and parallels
hemoglobin synthesis. Its regulation has been the focus of numerous studies and involves, at
least in part, sorting through the exosomal pathway [4–6]. After endocytosis, Fe(III)2 is
released from transferrin in the endosome upon acidification of the compartment. The
coupled apo-transferrin/TfR1 is recycled back to the plasma membrane, and iron is delivered
to the cytosol via the divalent metal transporter 1 (DMT1) [7, 8]. However, prior to its
released into the cytosol, iron has to be reduced to Fe(II), a role achieved by a family of
ferrireductases called STEAP (six-transmembrane epithelial antigen of prostate).
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Studies by Fleming et al. on nm1054, a spontaneous mutation that arose in the mouse,
allowed the identification of STEAP3 as the major ferrireductase in the erythroblast [9–11].
However, prior to the discovery of this mutant, STEAP3 had been named TSAP6 (Tumor
Supressor Activated Pathway 6) after it had been found to play a role in cancer. Indeed, a
series of studies identified TSAP6 as a gene activated in tumor suppression and reversion
after p53 activation [12–14]. In order to study the function of TSAP6/Steap3, we previously
generated knockout mice, and found that these mice presented with a microcytic anemia
along with a deregulation of TfR1 sorting and exosomal secretion [15]. However, the red
cell phenotype had not been characterized in depth, and the mechanism leading to the
microcytic anemia was unclear.
Here, using TSAP6/Steap3 knockout mice as a model, we investigated the consequences of
its ablation on the membrane stability of red blood cells and erythropoiesis. We undertook a
comprehensive hematologic characterization of the red cell compartment, and showed that
the microcytic, hypochromic anemia is characterized by a decrease in the membrane
deformability, increased fragmentation and resistance to osmotic stress. However, none of
the major transmembrane or cytoskeletal proteins were affected in their expression pattern,
precluding a problem in the vertical or horizontal linkages. Furthermore, red cell survival
was not compromised in knockout animals, but erythropoiesis was quantitatively affected,
resulting in altered ratios of erythroblasts stages. Altogether, these results suggest that the
microcytic anemia observed in TSAP6/Steap3 null mice is predominantly due to abnormal
erythropoiesis.
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Methods
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Mice
Generation of the TSAP6/Steap3 null mice was described previously [15]. All studies were
conducted on animals of at least 3 months of age, both male and female. Animal protocols
were reviewed and approved by the New York Blood Center Animal Care and Use
Committee.
Statistics
Data are presented as mean ± standard deviation, and differences between mean values were
tested for significance using the two-tailed Student t-test.
Genotyping
Mice were genotyped as previously described [15], using the following primers:
F1 5’-GAGTGACCACCTCTCTCAGTCC-3’,
R1 5’-AACACCGGTGACTACTGTGCTTTCG-3’,
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R2 5’-AAGGAACACTGTCTCCACCAGTCCC-3’.
TSAP6/Steap3 knockout mice are defined as tsap6Δ2–3. A typical result of the genotyping is
presented in Supplemental Figure 1.
Antibodies
Mouse monoclonal anti-human transferrin receptor (TfR) was from Invitrogen. Mouse
monoclonal anti-NHE-1, clone 4E9; and rabbit polyclonal anti-AQP-1 were from Millipore.
Mouse monoclonal anti-β-Actin was from Sigma Aldrich. Rabbit polyclonal antibodies
against spectrin, ankyrin, 4.1R, 4.2, 4.9, Band 3, Glycophorin A, Adducin and
Tropomodulin-1 were generated in our laboratory. Peroxidase-conjugated donkey anti-rabbit
IgG and sheep anti-mouse IgG were from Jackson ImmunoResearch Laboratories. Purified
rat anti-mouse CD16/CD32, FITC-conjugated rat anti-mouse Ter119, APC-conjugated rat
anti-mouse CD44, APC-Cy7-conjugated rat anti-mouse CD11b; CD45; and GR1 were from
BD Pharmingen.
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Automated cell counts
Whole blood was collected from the retroorbital sinus using EDTA-coated microhematocrit
capillaries. Complete blood counts were obtained using an automated hematology analyzer
(Advia 120 multispecies hematology analyzer, Bayer Healthcare).
Transmission electron microscopy
Red cells from wild type and TSAP6/Steap3 knockout mice were fixed in 2% (vol/vol)
glutaraldehyde in 0.1M sodium cacodylate (pH 7.4) for 1 hour at RT and washed three times
in 0.1M sodium cacodylate (200g, 10min, RT). Fixed cells were stained with 2% (vol/vol)
OsO4 buffered in 0.1M sodium cacodylate (1 hour, RT). Samples were dehydrated using
increasing concentrations of ethanol. Following dehydration, samples were incubated in
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propylene oxide/epon resin (50:50) and in propylene oxide/epon resin (25:75) for 1 hour at
RT each. Finally, samples were embedded in 100% epon resin overnight at 60°C. Specimens
were sectioned on RMC MTX ultramicrotome using a Diatome diamond knife, and imaged
on a FEI Tecnai 12 spirit TEM operated at 80 kV. All chemicals used for electron
microscopy were from Electron Microscopy Sciences.
Osmotic fragility
Red cells were isolated from whole blood by centrifugation (400g, 5min, 4°C), and washed
three times in PBS. Pellets were resuspended (50%, vol/vol) in normal saline solution (170
mM NaCl), and kept on ice. Fragility curve solutions were prepared by serial dilutions of a
290 mOsm osmotic fragility solution (145 mM NaCl; 8 mM Na2HPO4; 1 mM NaH2PO4).
Cells were then diluted six times in normal saline, and 10 µL of these diluted cells were
added to each assay tube. After incubation (20 min at RT), unlysed cells were pelleted
(400g, 5 min, RT), and the supernatant was collected. Percent of lysis was determined by
reading absorbance at 540nm.
Ektacytometry
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Cellular deformability and membrane stability was assessed by two methods, based on the
viscosity of the buffer in which the red cells were suspended. In the first approach (low
viscosity), whole red cells were resuspended in 3% (wt/vol) polyvinylpyrrolidone (PVP),
and exposed to an increased shear stress (0–150 dynes/cm2). This process was detected as an
increase in the deformability index (DI) as a function of the shear stress using an
ektacytometer as previously described [16] and reflects cellular deformability. In the second
approach (high viscosity), the cells were resuspended in 40% dextran (molecular weight=
40,000 kDa), and subjected to a constant applied shear stress of 750 dynes/cm2 for 10min to
measure membrane stability [17].
Density Gradients
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Blood was washed three times in PBS-0.5% (wt/vol) Bovine Serum Albumin (BSA, Sigma
Aldrich), 1 mM EDTA (Ethylene Diamine Tetra Acetate, Sigma Aldrich). Red cells were
then layered on top of an OptiPrepTM/PBS Density Gradient (1.083, 1.087, 1.091, 1.095,
1.100 g/mL), and ultracentrifuged at 141,000g for 30 min at RT (Beckman L7–65
Ultracentrifuge).
Western Blot
Red cell membrane fractions (Ghosts) were prepared as previously described [18]. Protein
samples were solubilized in Laemmli buffer, and separated by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) in 10% (wt/vol) polyacrylamide gels. After migration, samples
were electrophoretically transferred to nitrocellulose membrane (BioRad). Membranes were
subsequently blocked for 1 hour at RT in 4% (wt/vol) nonfat milk (BioRad), 1% (wt/vol)
Bovine Serum Albumin (BSA, Sigma Aldrich), PBS-T (137 mM NaCl, 10 mM phosphate,
pH7.4; 2.7 mM KCl; 0.1% Tween 20), and incubated with the indicated primary antibodies
overnight at 4°C. After three washes in PBS-T, membranes were incubated with the
secondary antibody [Horseradish Peroxidase (HRP) conjugated] for 1 hour at RT. Enhanced

Am J Hematol. Author manuscript; available in PMC 2016 March 01.

Blanc et al.

Page 5

chemiluminescence method (Pierce Chemical) was finally used to detect immunoreactive
bands.
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Flow cytometry
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After collection of the bone marrow and spleen of wild type and TSAP6/Steap3 null mice,
erythropoiesis was monitored as previously described [19]. Briefly, for leukocyte depletion
by negative selection, single cell suspensions from the bone marrow or spleen were
incubated with mouse CD45 microbeads (Miltenyi Biotech) for 15 min on ice. After one
wash in PBS-0.5% BSA, cells were subjected to magnetic separation using MACS-LS
separation columns (Miltenyi Biotech) according to the manufacturer’s instructions.
Leukocyte-depleted cells were resuspended in PBS 0.5% BSA, and blocked with a rat antimouse CD16/CD32 for 15min on ice. After blocking, cells were stained by adding a cocktail
of APC-Cy7-conjugated rat anti-mouse CD11b, APC-Cy7-conjugated rat anti-mouse CD45,
APC-Cy7-conjugated rat anti-mouse GR1, APC-conjugated rat anti-mouse CD44, and
FITC-conjugated rat anti-mouse Ter119 for 30 min ice in the dark. Cells were washed three
times in PBS 0.5% BSA (200g, 5min, 4°C), and fluorescence was acquired on a FACSCanto (Becton Dickinson). All data were subsequently analyzed using FlowJo v10.0.6 (Tree
Star).
Red Cell Survival
Red cell survival in wild type and TSAP/Steap3 null mice was evaluated as previously
described [20]. Briefly, 30 mg/ml EZ-link sulfo-NHS-Biotin (Thermo Scientific) was
injected in the tail vein of the mice. Blood was then collected once a week, and red cells
were pelleted and stained with PE-conjugated Streptavidin (BD Pharmingen). After
incubation (30 min at 4°C), cells were washed twice in PBS-0.5% BSA (200g, 5min, 4°C)
and fluorescence was acquired on a FACS-Canto (Becton Dickinson).

Results
The microcytic, hypochromic anemia observed in TSAP6/Steap3 null mice is associated
with decreased deformability, increased fragmentation and reduced osmotic fragility of the
red blood cells
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Phase microscopy analyses of peripheral blood from TSAP6/Steap3 knockout mice showed
aberrant red blood cell morphology (Figure 1A). Specifically, we found that erythrocytes
were heterogeneous in terms of size and shape, characteristics of anisocytosis. To gain
further insights into the morphology of these red cells, we performed transmission electron
microscopy. As shown in Figure 1B, one can clearly observe a decrease in both the size and
volume of the red cells from TSAP6/Steap3 knockout mice as well as the presence of small
particles, reminiscent of fragmented or fragmenting erythrocytes (red arrows). In line with
these results, the hematologic parameters obtained by automated blood counts (Table 1)
showed a reduced mean corpuscular volume (MCV), decreased cell hemoglobin content
(MCH) and a decreased mean cell hemoglobin concentration (MCHC), an increased red
blood cell distribution width (RDW) and an elevated reticulocyte count. These parameters
reflect a microcytic (reduced MCV), hypochromic (reduced MCHC) anemia. The
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reticulocyte count is elevated, although moderately, and indicates that the anemia is
proliferative.
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We hypothesized that the red cell fragmentation was due to a decrease in membrane
deformability. To test this hypothesis, we assessed red cell deformability by ektacytometry.
Erythrocytes were resuspended in 3% (wt/vol) PVP-PBS, and subjected to increased shear
stress (0–150 dynes/cm2). In these conditions, red cells from TSAP6/Steap3 knockout
animals deformed significantly less than their wild type counterparts (Figure 1C) implying
reduced cellular deformability. In addition, when these assays were performed in high
viscosity conditions (40% [wt/vol] dextran), one can observe a fragmentation in the
knockout samples, suggesting that these red blood cells possess decreased membrane
mechanical stability (Figure 1D). Another approach to assess the alterations in red cell
surface area to volume ratio is based on measuring osmotic fragility of cells. When we
subjected erythrocytes to this test, we found that the 50% lysis for the TSAP6/Steap3
knockout was 80 mOsm compared to 165 mOsm for the wild type (Figure 1E) implying
decreased volume-to-surface area ratio. Finally, when we loaded red blood cells from wild
type and knockout mice on top of a discontinuous density gradient, we found a different
distribution of erythrocytes, with very light cells in the knockout only (Figure 1E). In
accordance with an elevated reticulocyte count (Table 1), some of the cells found in the
lighter fractions were reticulocytes, as measured by flow cytometry using thiazole orange
(data not shown). However, this distribution is mainly a reflection of the decreased
hemoglobin concentration of red cells in the TSAP6/Steap3 knockout model.
The membrane defect is not due to a change in the expression levels of a major red cell
membrane protein
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In an attempt to understand the membrane defects described above, we measured the
expression levels of major skeletal and transmembrane proteins, notably those usually
affected in common red cell membrane disorders [21]. Coomassie blue staining of red cell
membrane proteins (Figure 2A) indicate no major difference between wild type and
knockout samples; although, we consistently found a band around 16kDa (black arrow),
which may correspond to the globin chains in the TSAP6/Steap3 knockout, as previously
reported in a model of severe β-thalassemia [22]. In addition, when we performed western
blot analyses of the major cytoskeletal components, namely spectrin, ankyrin, adducin, 4.1R,
4.2, 4.9, tropomodulin and actin, we found no differences in their expression levels (Figure
2B). On the other hand, the transmembrane proteins NHE-1 and CD71 were higher in the
knockout compared to the wild type, in contrast to Band 3, Glycophorin A (GPA) and
Aquaporin-1 (AQP-1) that did not display a differential expression. NHE-1 and CD71 are
down regulated at the reticulocyte stage, and the higher expression levels may be explained
by the higher reticulocyte count found in the knockout animals (Table 1). However, we
found a similar expression pattern for the main skeletal and transmembrane proteins that are
involved in red cell membrane disorders [23]. These data preclude disruption of the vertical
or horizontal linkages as the etiology of the membrane defect.
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Abnormal erythroid maturation is part of the underlying mechanism leading to the
microcytic anemia
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Anemia can be due to defects in the production or destruction of red blood cells. The
membrane fragmentation observed in the red cells from knockout animals led us to
investigate the possibility of a problem in red cell survival. To test this hypothesis, we
labeled red blood cells with biotin, and followed their clearance over time as described [20].
We did not find any differences between wild type and TSAP6/Steap3 knockout in terms of
in vivo clearance (Figure 3). These data suggest that red cell survival is unaffected.
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In our previous study [15], we found that the spleen of TSAP6/Steap3 knockout animals was
enlarged, with an expansion of the red pulp, reminiscent of stress erythropoiesis [24]. In
order to confirm this hypothesis, we collected the spleen of both wild type and knockout
mice. All mice were at least three months old, to avoid any physiologic splenic
erythropoiesis that is encountered after birth (Mohandas N. and An X., unpublished data).
After CD45 depletion, FACS analyses showed that only one main population remained in
the wild type (Supplemental Figure 2A, left panel), while a second population was observed
in the knockout (Supplemental Figure 2A, right panel). Moreover, when we used CD44 and
Forward Scatter (FSC) as markers of terminal erythroid differentiation, we found that
erythroid precursors were present only in the spleen of knockout mice (Supplemental Figure
2B, right panel), confirming stress erythropoiesis in these animals.
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The main compartment for red cell production is the bone marrow, which has the capacity to
double its erythroid output under stress conditions [19]. Therefore, in order to delineate the
mechanism of anemia and quantify erythropoiesis in TSAP6/Steap3 knockout mice, we
collected the bone marrow from these animals, and used CD44 and FSC as markers of
differentiation as we did for the spleen. After myeloid cell depletion and positive gating of
the living erythroid cell population, two main populations are identified based on the
morphological complexity of the cells (forward scatter versus side scatter, Figure 4A) in the
bone marrow of both wild type and TSAP6/Steap3 knockout mice. However, in the
knockout animals, we found an increase in the CD44hi/FSChi population and a decrease in
the CD44low/FSClow population (Figure 4B). We expressed the six distinguishable erythroid
populations based on their CD44 expression as a function of FSC, and then compared the
wild type and TSAP6/Steap3 for their size (Figure 4C). We found that each population had
comparable sizes, up to the reticulocyte stage, where cells from knockout samples were
smaller. These results suggest that the decreased size is a late, but continuous process,
starting at the transition between the orthochromatic and reticulocyte stages, i.e. when
enucleation takes place. We quantitated the proportion of erythroblasts at each distinct stage
of maturation, and found a decrease in the amount of proerythroblasts in the knockout
animals (Figure 4D). The progression towards orthochromatic erythroblasts was affected in
the bone marrow of the TSAP6/Steap3 knockout, and we found a ratio of 1:4:16:24 from the
pro- to orthochromatic stage. Altogether, these results demonstrated that there is an
increased production of precursors both in the spleen (Supplemental Figure 2) and bone
marrow (Figure 4) of TSAP6/Steap3 knockout mice. Moreover, a difference in size
observed in mature red cells from knockout animals compared to wild type occurs at the
transition between the orthochromatic and reticulocyte stages.
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Discussion
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In the present study, we provide a comprehensive hematologic characterization of TSAP6/
Steap3 knockout mice, focusing on the red cell compartment. We confirmed that knockout
red cells display marked microcytosis and demonstrated that these cells are mechanically
unstable, indicative of cell fragmentation. These results coupled with increased resistance to
osmotic stress suggest the volume-to-surface area ratio is altered in TSAP6/Steap3 knockout
mice, a finding observed in iron deficiency and thalassemia [25, 26].
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We could not link the membrane fragmentation defect observed to any of the major
components of the two main protein complexes. Several studies have demonstrated the role
played by reactive oxygen species (ROS) on the membrane stability and the survival of the
red blood cell [27–29]. In addition, TSAP6/Steap3 was identified first as a ferrireductase.
One may suggest that its genetic ablation could lead to the accumulation of Fe(III), the
oxidized form of iron, which would be deleterious for the erythrocyte. When we measured
the ROS levels in the red cells, however, we did not find any differences between wild type
and knockout samples (data not shown). Our transmission electron microscopy studies did
not reveal any inclusions reminiscent of globin precipitates (Figure 1B). Further, the density
gradients revealed very low density cell populations in knockout mice (Figure 1F), and we
consistently found a band corresponding to the globin chains on the coomassie stained gels
of red cell membrane proteins (Figure 2A). We propose that maturing erythroblasts cannot
reduce Fe(III), and therefore, cannot make functional heme. The globin chains, nevertheless,
are synthetized normally and accumulate. As a result, there is a defect in the hemoglobin
synthesis in TSAP6/Steap3 knockout mice. We suggest that the microcytic, hypochromic
anemia observed in the TSAP6/Steap3 knockout mouse model is linked to iron deficiency,
as in the nm1054 model [9], rather than a defect in the globin synthesis.
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In order to assess the underlying mechanism of the anemia in TSAP6/Steap3 knockout mice,
we used our recently described method that enables the quantitation of distinct stages of
terminal erythroid differentiation both in normal and pathological conditions. Based on the
cell size and the expression levels of CD44, we found in wild type mice a ratio of 1:2:6:15
from proerythroblasts to orthochromatic erythroblasts. However, in the bone marrow of the
TSAP6/Steap3 knock out animals, we found a ratio of 1:4:16:24, reflecting a higher number
of divisions (Figure 4). A similar proportion of 1:3.5 for proerythroblast:basophilic
erythroblast was found in the Hbbth1/th1mouse, a model of β-thalassemia intermedia [19, 30].
In the thalassemia model, the ratios normalize after the basophilic stage, which is likely due
to erythroid precursor apoptosis [31]. In the TSAP6/Steap3 model however, the number of
polychromatophilic erythroblasts remains increased compared to the wild type. This raises
the question of imbalance among proliferation, differentiation and apoptosis in the TSAP6/
Steap3 knockout model. In our previous study, we showed that in the spleen of the knockout
animals, Ter119 positive cells were less prone to apoptosis after γ-irradiation than their wild
type counterparts [15]. Furthermore, in the context of cancer, TSAP6 knockdown has been
shown to lead to the inhibition of apoptosis [13]. Therefore, we believe that the increased
number of precursors can divide and differentiate, thereby producing more red cells with
less hemoglobin. On the contrary, in the thalassemia model, many progenitors undergo
apoptosis, and therefore lead to a reduced number of red cells produced. Taken together, our
Am J Hematol. Author manuscript; available in PMC 2016 March 01.
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observations in the knockout mice suggest the possibility that TSAP6/Steap3 may play a
role beyond its function as a ferrireductase. Alternatively, the loss of its TSAP6/Steap3
ferrireductase activity may influence erythroid differentiation by mechanisms independent
of its effects on iron delivery from the plasma.
The red cells produced are smaller, but when we compared each progenitor population based
on their size, we found that they were comparable up to the reticulocyte stage. Membrane
remodeling is an integral part of erythropoiesis and occurs, for the most part, during the very
late stages, namely during enucleation and reticulocyte maturation [32, 33]. The nucleus is
extruded with a significant amount of plasma membrane, and the membrane remodeling
follows with the removal of the endosomal compartment through the exosomal pathway
[33]. It is therefore tempting to suggest that, in the knockout model, more membrane is
partitioned with the nucleus than reticulocyte during its expulsion. This could explain the
difference in size observed at the reticulocyte stage. Finally, the membrane fragmentation
observed in mature red cells exacerbates size reduction.
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In conclusion, our work expands previous studies that were performed on this knockout
mouse model, and offers an explanation for the mechanism underlying the microcytic
anemia. While TSAP6/Steap3 null mice are phenotypically similar to some extent to murine
models of thalassemia and congenital erythropoietic porphyria, presenting with microcytosis
and decreased MCHC, their etiologies differ [31, 34]. Abnormal terminal erythroid
differentiation appears to account for the anemia observed in our knockout mice, and
suggests Steap3 is functionally important in erythroid differentiation. Whether this function
is entirely related to its properties as a ferrireductase remains to be determined; however our
data in the knockout mice demonstrate a phenotype clearly distinct from deficient
transferrin-mediated iron delivery. As nonsense mutations in the TSAP6/STEAP3 gene [35]
have been reported in patients with severe hypochromic anemia, future studies will be aimed
at characterizing erythropoiesis in these patients (e.g. using CD34+ cells from peripheral
blood) in order to investigate how our findings translate to human disease. Taken together,
these results suggest that TSAP6/Steap3 regulates mammalian erythropoiesis. We believe
that our study has important implications in the fields of iron deficiency, red cell membrane
biology and erythropoiesis.
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Figure 1. Phenotype of red cells from TSAP6/Steap3 KO mice

NIH-PA Author Manuscript

(A) Phase contrast microscopy of peripheral blood from wild type (left panel) or TSAP6/
Steap3 knockout mice (right panel) shows heterogeneity in the shape of the red blood cells.
(B) This is confirmed by transmission electron microscopy, where fragmentation of
erythrocytes is apparent (red arrows). In addition, cells are smaller. Bar represents 2 µm. (C–
D) Membrane deformability assessments by ektacytometry in 3% PVP (C) or 40% dextran
(D) show reduced deformability for TSAP6/Steap3 KO red blood cells. (E) Osmotic fragility
is also reduced in knockout animals. Data presented X ± Standard deviation, n=4 in each
group. All animals were 4 months of age. (F) Density gradients performed on red cells show
a different density distribution in the knockout samples.
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Figure 2. Expression levels of major red cell membrane proteins

(A) Coomassie blue staining of SDS-PAGE gel of red cell membranes (ghosts) shows no
major differences between wild type and Steap3 KO mice in terms of total protein contents.
(B–C) Western blot analyses performed on ghosts from 2 wild type and 2 TSAP6/Steap3
KO mice for cytoskeleton proteins (B) or transmembrane proteins (C). Only NHE-1 and
CD71 expression levels were increased in ghosts from KO animals.

NIH-PA Author Manuscript
Am J Hematol. Author manuscript; available in PMC 2016 March 01.

Blanc et al.

Page 14

NIH-PA Author Manuscript
NIH-PA Author Manuscript

Figure 3. Red cell survival

Red cell lifespan was followed after biotin injections at day 0, and measured as a decrease in
the amount of biotinylated red blood cells over time. There was no significant difference
between wild type and TSAP6/Steap3 knockout animals. Data presented X ± Standard
Deviation, n=3 in each group. All animals were 4 months of age.
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Figure 4. Analysis of bone marrow erythropoiesis
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(A) Bone marrow from WT and TSAP6 KO animals were collected and CD45 depletion
was performed as described in Material and Methods. Representative pattern obtained after
depletion, forward scatter (FSC) versus side scatter (SSC). (B) CD44 versus FSC plots
demonstrate increased numbers of precursors (CD44hi/FSChi) in the KO animals (right
panels). (C) Analyses and comparisons of the size of each distinguishable population
between wild type and TSAP6/Steap3 knockout mice demonstrate that the loss of surface
area appears after the orthochromatic stage (OrthoEB). (D) Quantification of the four
distinct erythroblastic populations. Data presented X ± Standard deviation, n=5 in each
group. **P ≤ 0.01 vs wild type; ***P ≤ 0.001 vs wild type. All animals were 4 months of
age. The proportion of erythroblasts at each stage was normalized to the total number of
nucleated erythroblasts.
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Hematologic parameters
RBC
(×106/µL)

HGB
(g/dL)

HCT
(%)

MCV
(fL)

MCH
(pg)

MCHC
(g/dL)

CH
(pg)

RDW
(%)

Retics
(%)

Abs Retics
(×106/µL)

Wild Type

9.5 ± 0.6

13.9 ± 0.6

43.3 ± 6.0

45.2 ± 3.6

14.5 ± 0.3

32.3 ± 3.1

13.9 ± 0.4

13.8 ± 0.8

2.6 ± 1.0

0.3 ± 0.1

TSAP6 KO

15.9 ± 1.2***

9.2 ± 0.9***

34.3 ± 6.4*

21.5 ± 3.2***

5.8 ± 0.3***

27.2 ± 2.8**

5.7 ± 0.2***

27.2 ± 2.2***

5.7 ± 3.0*

0.9 ± 0.4*

Data presented X ± SD, n=6 in each group.
*

P ≤ 0.05 vs wild type;

**

P ≤ 0.01 vs wild type;

***

P ≤ 0.001 vs wild type.

All animals were at least 4 months of age.
RBC: Red Blood Cells; HGB: hemoglobin; HCT: Hematocrit; MCV: Mean Corpuscular Volume; MCH: Mean Corpuscular Hemoglobin; MCHC:
Mean Cell Hemoglobin Concentration; CH: Corpuscular Hemoglobin; RDW: Red cell Distribution Width; Retics: Reticulocyte count; Abs Retic:
Absolute Reticulocyte Count.
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